Lupus Nephritis
📧 Sign up to get email alerts when something new happens for Lupus Nephritis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2023-05-18Clinical Trial Update: Trial of Belimumab Combined With Multi-target Induction Therapy in Lupus Nephritis [Phase 3]
Phase 3 trial investigating belimumab with multi-target induction therapy for lupus nephritis; current status is unknown with remission as a…
-
CLINICAL_TRIALS trial_result · 2023-02-08Clinical Trial Update: Mesenchymal Stromal Cells (MSC´s) in Renal Lupus [Phase 2]
A Phase 2 clinical trial evaluating mesenchymal stromal cells for systemic lupus erythematosus and lupus glomerulonephritis.
-
CLINICAL_TRIALS trial_result · 2023-01-04Clinical Trial Update: Efficiency of Use of Baracetinib in Treatment of Lupus Nephritis [Phase 3]
Phase 3 clinical trial update for Baracetinib in lupus nephritis.
-
CLINICAL_TRIALS trial_result · 2022-12-14Clinical Trial Update: Aurinia Renal Assessments 2: Aurinia Renal Response in Lupus With Voclosporin [Phase 3]
Phase 3 trial results of voclosporin for lupus nephritis completed; assesses renal response in lupus nephritis patients.
-
CLINICAL_TRIALS trial_result · 2022-11-30Clinical Trial Update: The Study of Comparing the Efficacy and Safety of Human Umbilical Cord MSCs and Low-dose IL-2 in the Treatment of LN [Phase 3]
Phase 3 trial comparing human umbilical cord mesenchymal stem cells with low-dose IL-2 for treatment of systemic lupus erythematosus and lup…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2022-10-17Clinical Trial Update: An Investigational Study to Evaluate the Safety and Effectiveness of BMS-986165 With Background Treatment in Participants With Lupus Nephritis [Phase 2]
Phase 2 trial assessing safety and effectiveness of BMS-986165 with background treatment in lupus nephritis; study terminated with results p…
-
CLINICAL_TRIALS trial_result · 2022-08-10Clinical Trial Update: MMF Versus CYC in the Induction Therapy of Pediatric Active Proliferative LN [Phase 4]
A Phase 4 trial update comparing mycophenolate mofetil against cyclophosphamide in induction therapy for pediatric active proliferative lupu…
-
CLINICAL_TRIALS trial_result · 2022-07-13Clinical Trial Update: An Exploratory Maintenance Trial of BI 655064 in Patients With Lupus Nephritis [Phase 2]
Phase 2 exploratory maintenance trial of BI 655064 in lupus nephritis has completed; results posted in 2022.
-
CLINICAL_TRIALS trial_result · 2022-06-21Clinical Trial Update: Comparison between2 Drugs in Lupus Nephritis [Phase 4]
Phase 4 clinical trial comparing two drugs in lupus nephritis has completed.
-
CLINICAL_TRIALS trial_result · 2022-03-09Clinical Trial Update: A Study of Laquinimod in Participants With Systemic Lupus Erythematosus (SLE) Active Lupus Nephritis [Phase 2]
Phase 2 study of laquinimod in participants with active lupus nephritis has completed; results posted in 2022.
-
CLINICAL_TRIALS trial_result · 2022-03-03Clinical Trial Update: Minimizing Glucocorticoid Administration in Patients With Proliferative Lupus Nephritis [Phase 4]
Phase 4 trial update focusing on minimizing glucocorticoid use in patients with proliferative lupus nephritis.
-
CLINICAL_TRIALS trial_result · 2021-11-24Clinical Trial Update: Safety and Efficacy of Two Doses of Anifrolumab Compared to Placebo in Adult Subjects With Active Proliferative Lupus Nephritis [Phase 2]
Phase 2 trial evaluating two doses of anifrolumab versus placebo in adults with active proliferative lupus nephritis completed with posted r…
-
CLINICAL_TRIALS trial_result · 2021-09-23Clinical Trial Update: Efficacy and Safety of Artesunate Plus Standard of Care in Active Lupus Nephritis [Phase 4]
Phase 4 trial evaluating artesunate in combination with standard of care for active lupus nephritis to assess efficacy and safety.
-
CLINICAL_TRIALS trial_result · 2021-07-12Clinical Trial Update: Dose Finding, Efficacy and Safety of BI 655064 in Patients With Active Lupus Nephritis [Phase 2]
A Phase 2 dose-finding study of BI 655064 in patients with active lupus nephritis has been completed, with results on efficacy and safety re…
-
CLINICAL_TRIALS trial_result · 2021-06-16Clinical Trial Update: Aurinia Renal Response in Active Lupus With Voclosporin [Phase 3]
Phase 3 trial update on voclosporin for Lupus Nephritis completed with results posted in 2021.
-
CLINICAL_TRIALS trial_result · 2021-05-19Clinical Trial Update: Sirolimus in Treatment of Proteinuric Flares of Lupus Nephritis [Phase 2, Phase 3]
Phase 2/Phase 3 trial evaluating sirolimus for treatment of proteinuric flares in lupus nephritis.
-
CLINICAL_TRIALS trial_result · 2021-05-18Clinical Trial Update: AURA-LV: Aurinia Urinary Protein Reduction Active - Lupus With Voclosporin (AURA-LV) [Phase 2]
Phase 2 trial update for voclosporin in lupus nephritis (AURA-LV) has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2021-03-19Clinical Trial Update: Aurinia Early Urinary Protein Reduction Predicts Response [Phase 2]
Phase 2 trial update suggests that early reduction in urinary protein predicts response in lupus nephritis.
-
CLINICAL_TRIALS trial_result · 2021-02-01Clinical Trial Update: Fixed-dose Versus Concentration-controlled Mycophenolate Mofetil for the Treatment of Active Lupus Nephritis [Phase 4]
Phase 4 trial comparing fixed-dose versus concentration-controlled mycophenolate mofetil in active lupus nephritis has been terminated.
-
CLINICAL_TRIALS trial_result · 2020-12-22Clinical Trial Update: A Study to Evaluate Ocrelizumab in Patients With Nephritis Due to Systemic Lupus Erythematosus (BELONG) [Phase 3]
Phase 3 trial evaluating ocrelizumab for nephritis due to systemic lupus erythematosus was terminated; results posted in 2020.
-
CLINICAL_TRIALS trial_result · 2020-09-04Clinical Trial Update: Low-dose VS High-dose IV Cyclophosphamide for Proliferative LN in Children [Phase 4]
Phase 4 trial update on low-dose versus high-dose IV cyclophosphamide for proliferative lupus nephritis in children; study terminated.
-
CLINICAL_TRIALS trial_result · 2020-07-07Clinical Trial Update: Efficacy and Safety of Belimumab in Patients With Active Lupus Nephritis [Phase 3]
Phase 3 trial update on belimumab for active lupus nephritis reporting efficacy and safety results.
-
CLINICAL_TRIALS trial_result · 2020-02-26Clinical Trial Update: A Study to Evaluate the Safety and Efficacy of Obinutuzumab Compared With Placebo in Participants With Lupus Nephritis (LN) [Phase 2]
Phase 2 trial evaluating obinutuzumab versus placebo in lupus nephritis has completed, with results posted in February 2020.
-
CLINICAL_TRIALS trial_result · 2019-10-31Clinical Trial Update: Efficacy of Lower Dose Prednisolone in the Induction of Remission of Lupus Nephritis [Phase 4]
Phase 4 trial update evaluating lower-dose prednisolone for inducing remission in lupus nephritis.
-
CLINICAL_TRIALS trial_result · 2019-10-31Clinical Trial Update: Metformin In Prevention of Lupus Nephritis [Phase 4]
A Phase 4 clinical trial investigating metformin for the prevention of lupus nephritis is listed, but current status is unknown.